Alanine Inhibition of Pyruvate Kinase in Gliomas and Meningiomas. A Diagnostic Tool in Surgery for Gliomas?
Overview
Authors
Affiliations
In gliomas a shift was found in the composition of enzymes, manifested by abnormal inhibition of pyruvate kinase by alanine. This study demonstrates the appearance of the MII-type isoenzyme in various gliomas. This MII type is also found in meningiomas but not in normal brain tissue. The method of enzyme examination described may be valuable as a diagnostic aid in the surgery of gliomas.
A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme.
Verma H, Cholia R, Kaur S, Dhiman M, Mantha A Metab Brain Dis. 2021; 36(5):751-765.
PMID: 33651273 DOI: 10.1007/s11011-021-00690-y.
Konno M, Ishii H, Koseki J, Tanuma N, Nishida N, Kawamoto K Regen Ther. 2019; 1:63-71.
PMID: 31245442 PMC: 6581773. DOI: 10.1016/j.reth.2015.01.001.
Chaman N, Iqbal M, Siddiqui F, Gopinath P, Bamezai R J Biol Chem. 2015; 290(39):23803-15.
PMID: 26269597 PMC: 4583024. DOI: 10.1074/jbc.M115.657411.
Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation.
Lunt S, Muralidhar V, Hosios A, Israelsen W, Gui D, Newhouse L Mol Cell. 2014; 57(1):95-107.
PMID: 25482511 PMC: 4289430. DOI: 10.1016/j.molcel.2014.10.027.
Anchorless 23-230 PrPC interactomics for elucidation of PrPC protective role.
Zafar S, Asif A, Ramljak S, Tahir W, Schmitz M, Zerr I Mol Neurobiol. 2014; 49(3):1385-99.
PMID: 24390569 DOI: 10.1007/s12035-013-8616-2.